BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2011
View Archived Issues
Clinical findings presented for sirukumab in lupus and rheumatoid arthritis
Read More
New mechanism explored for treating Alzheimer's disease
Read More
New LXR agonist displays promising antiatherosclerotic effects in vivo
Read More
Korean investigators discover new biomarker of disease activity in rheumatoid arthritis
Read More
Results reported from phase I trial of enavatuzumab in advanced solid tumors
Read More
Updated results presented from ongoing first-in-patient trial of PF-04691502
Read More
Amgen tests antibody-drug conjugate targeting EGFRvIII
Read More
New compounds for bone disorders prepared by Daiichi Sankyo
Read More
Astellas Pharma prepares novel NPT-IIb inhibitors
Read More
FDA approves Medtronic's iPro2 professional CGM system
Read More
Novel tyrosine-protein kinase SYK inhibitors designed by GSK
Read More
Transition Therapeutics set to close USD 5 million private placement
Read More
UCB decides on option agreement to license SYN-118
Read More
Japanese researchers synthesize new PDE4B inhibitors
Read More
Takeda Pharmaceuticals reports novel acetyl-CoA carboxylase inhibitors
Read More
Advaxis completes pre-IND meeting for ADXS-HER2
Read More
Neuralstem injects first patient with stem cells in cervical region of spine
Read More
Takeda files NDA for fixed-dose tablet of alogliptin/metformin
Read More
FDA approves Transcept's insomnia drug Intermezzo
Read More
Mesoblast and FDA agree on adult stem cell trial in type 2 diabetes
Read More
Summit's SMT-C1100 granted orphan drug status in Duchenne's muscular dystrophy
Read More
Phase II trial of RP-G28 in lactose intolerance completed
Read More
Aeterna Zentaris licenses anticancer agent to Hikma
Read More
Cipher submits amendment to NDA for novel acne treatment
Read More
NICE decides not to recommend Lucentis for treatment of macular edema
Read More